The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Radhakrishnan Karthik since 2013.
This trader's CIK number is 1573327.
At the time of last reporting, Radhakrishnan Karthik was the Chief Financial Officer of Monopar Therapeutics. (stock ticker symbol MNPR).
Also see all insider trading activities at Monopar Therapeutics.
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2015 | OPXA | 0 | $0 | 0 | $0 | 50,000 | $0 |
2013 | OPXA | 58,000 | $88,600 | 0 | $0 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2024 | MNPR | 1,550 | $25,187 | 0 | $0 | 0 | $0 |
1. Acer Therapeutics Inc. (OPXA)
2. Monopar Therapeutics (MNPR)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2015-04-08 | OPXA | Option Ex | 50,000 | .00 | 0 |
2013-12-18 | OPXA | Buy | 8,000 | 1.70 | 13,600 |
2013-08-08 | OPXA | Buy | 50,000 | 1.50 | 75,000 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2024-10-28 | MNPR | Buy | 1,550 | 16.25 | 25,187 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Radhakrishnan Karthik (Chief Financial Officer of Monopar Therapeutics at the time of this reporting) see the Securities and Exchange Commission (SEC) website.